Literature DB >> 1731605

Pulmonary status of habitual cocaine smokers.

D P Tashkin1, M E Khalsa, D Gorelick, P Chang, M S Simmons, A H Coulson, H Gong.   

Abstract

We determined the prevalence of respiratory symptoms and lung dysfunction in a large sample of habitual smokers of freebase cocaine ("crack") alone and in combination with tobacco and/or marijuana. In addition, we compared these findings with those in an age- and race-matched sample of nonusers of crack who did or did not smoke tobacco and/or marijuana. A detailed respiratory and drug use questionnaire and a battery of lung function tests were administered to (1) a convenience sample of 202 habitual smokers of cocaine (cases) who denied intravenous drug abuse and (2) a reference sample of 99 nonusers of cocaine (control subjects). The cocaine smokers (85% black) included the following: 68 never-smokers of marijuana, of whom 43 currently smoked tobacco and 25 did not, and 134 ever-smokers of marijuana (42 current and 92 former), of whom 92 currently smoked tobacco and 42 did not. The control subjects (96% black) included the following: 69 never-smokers of marijuana, of whom 26 currently smoked tobacco and 43 did not, and 30 ever-smokers of marijuana (18 current and 12 former), of whom 21 currently smoked tobacco and 9 did not. Cases smoked an average of 6.5 g cocaine per week for a mean of 53 months. The median time of the most recent use of crack prior to study was 19 days (range less than 1 to 180 days). After controlling for the use of other smoked substances, frequent crack use was associated with: (1) a high prevalence of at least occasional occurrences of acute cardiorespiratory symptoms within 1 to 12 h after smoking cocaine (cough productive of black sputum [43.7%], hemoptysis [5.7%], chest pain [38.5%], usually worse with deep breathing, and cardiac palpitations [52.6%]) and (2) a mild but significant impairment in the diffusing capacity of the lung.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731605     DOI: 10.1164/ajrccm/145.1.92

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 2.  Respiratory toxicities from stimulant use.

Authors:  T E Albertson; W F Walby
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers.

Authors:  Petal A H M Wijnen; Otto Bekers; Marjolein Drent
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

Review 4.  Lung disease induced by drug addiction.

Authors:  M K Benson; A M Bentley
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

Review 5.  Marijuana. Respiratory tract effects.

Authors:  B E Van Hoozen; C E Cross
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

6.  Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program.

Authors:  Elise D Riley; David Vlahov; Steven Huettner; Peter Beilenson; Margaret Bonds; Richard E Chaisson
Journal:  J Urban Health       Date:  2002-03       Impact factor: 3.671

7.  Acute Pulmonary Injury after Inhalation of Free-Base Cocaine: A Case Report.

Authors:  Laura J Bontempo; Phillip D Magidson; Bryan D Hayes; Joseph P Martinez
Journal:  J Acute Med       Date:  2017-06-01

8.  Outcomes of cocaine-induced gastric perforations repaired with an omental patch.

Authors:  Kevin M Schuster; William J Feuer; Erik S Barquist
Journal:  J Gastrointest Surg       Date:  2007-08-15       Impact factor: 3.452

Review 9.  Stimulants and the lung : review of literature.

Authors:  Will Tseng; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

10.  Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice.

Authors:  Sandra M Wells; Mary C Buford; Sarah N Braseth; James D Hutchison; Andrij Holian
Journal:  Inhal Toxicol       Date:  2008-07       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.